Resources Contact Us Home
Modified factor VIII

Image Number 6 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Aisle barrier
Image capture system and method
Extension of physical downlink control channel coverage
Generation, display, and manipulation of measurements in computer graphical designs
Method for radiation sterilization of medical devices
Light barrier and method for detecting objects
LCD television set capable of external connection with application processor
  Randomly Featured Patents
Preheated trough for molten metal transfer
Thick film low value high frequency inductor
Method and computer program product for subdivision generalizing uniform B-spline surfaces of arbitrary degree
Valve with seal ring having edge-welded laminations
Container for garbage
Multi-purpose network diagnostic modules
Roll shifting system for rolling mills
Sulfonamide derivatives
High performance power device
Charged state estimating device and charged state estimating method of secondary battery